Press release from Companies
Published: 2019-10-09 09:47:36
The HoloMonitor unit purchased for a retail price by National Institutes of Health (NIH) has been delivered and sold by PHI Inc. in Boston Massachusetts, USA, a fully owned subsidiary to Phase Holographic Imaging PHI AB.
The order is the result of NIH"s non-competitive procurement of HoloMonitor, which the company announced on September 11, 2019. For additional information, please contact: Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
Carolina Silvandersson
E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis
